Megestrol Alternatives Compared
| Megestrol | Medroxyprogesterone | Norethindrone |
|
|---|
| Megestrol | Medroxyprogesterone | Norethindrone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Abnormal Uterine Bleeding, AIDS Related Wasting, Anorexia, Breast Cancer - Palliative, Cachexia, Endometrial Cancer, Endometrial Hyperplasia, Hot Flashes, Weight Loss (Underweight)... View more |
Prescription only
Prescribed for Abnormal Uterine Bleeding, Amenorrhea, Endometriosis, Birth Control, Endometrial Cancer, Endometrial Hyperplasia - Prophylaxis, Gender Affirming Hormone Therapy , Gender Dysphoria... View more |
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometriosis, Amenorrhea, Gender Affirming Hormone Therapy , Birth Control. norethindrone may also be used for purposes not listed in this medication guide. |
Related suggestions Abnormal Uterine Bleeding
Popular comparisons
|
|||||||||||||||||||||||
| More about Megestrol | More about Medroxyprogesterone | More about Norethindrone | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Megestrol has an average rating of 7.4 out of 10 from a total of 133 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 19% reported a negative effect. |
Medroxyprogesterone has an average rating of 4.5 out of 10 from a total of 2453 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 51% reported a negative effect. |
Norethindrone has an average rating of 4.9 out of 10 from a total of 1551 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 45% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: megestrol side effects in more detail. |
See also: medroxyprogesterone side effects in more detail. |
See also: norethindrone side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all megestrol prices |
View all medroxyprogesterone prices |
View all norethindrone prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Megace ES | Depo-Provera, depo-subQ provera 104, Provera | Affodel, Camila, Deblitane, Emzahh, Errin, Heather, Incassia, Jencycla, Lyleq, Lyza, Nor-QD, Norlyda, Norlyroc, Sharobel, Tulana View more | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
20 hours |
401 hours |
10 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 148 drugs are known to interact with megestrol:
|
A total of 230 drugs are known to interact with medroxyprogesterone:
|
A total of 247 drugs are known to interact with norethindrone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
August 18, 1971 |
June 18, 1959 |
April 21, 1982 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.